SCHEMBL20652976

SCHEMBL20652976

CC(C)n1c(=O)n(CCCO)c(=O)c2c1nc(-c1cccnc1OC[C@@H]1CC1(F)F)n2Cc1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.39
▸ TRPC4 Q9UBN4 2/20 0.37
▸ TRPC5 Q9UL62 2/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ TRPC1 P48995 1/20 0.36
▸ PCSK9 Q8NBP7 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALPL P05186 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652949 1.00 PKM (0.39) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20652832 1.00 PKM (0.39) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20655924 0.95 PKM (0.38) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20656213 0.95 TRPC4 (0.37) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20656223 0.95 TRPC4 (0.37) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20652764 0.94 ADORA3 (0.40) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20653036 0.94 ADORA3 (0.40) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20653037 0.94 ADORA3 (0.40) PKMTRPC4TRPC5KCNH2TRPC1
SCHEMBL20656242 0.93 PKM (0.41) PKMNPSR1ADORA3MAPK1GFER
SCHEMBL20652731 0.91 PKM (0.40) PKMTRPC4TRPC5KCNH2TRPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 PKM 1869/4885TRPC4 3/4885TRPC5 1/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 PKM 2064/4885TRPC4 2/4885TRPC5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback